Open AccessGiant Cell Tumor of Bone
Author(s) -
Cavanna Luigi,
Biasini Claudia,
Monfredo Michela,
Maniscalco Pietro,
Mori Monica
Publication year - 2014
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2014-0267
Subject(s) - denosumab , medicine , giant cell tumor of bone , disease , giant cell , osteoporosis , pathology
The role of enhanced fluorodeoxyglucose F 18 uptake of giant cell tumor of bone (GCTB) should be mentioned in an overview such as that reported by van der Heijden et al., with regard not only to the response to denosumab treatment for unresectable GCTB but also to the clinical implications for the diagnosis of this disease.